Methods for the treatment of disorders of the cardiac vascular s

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514656, 514659, A61K 3113, A61K 3114, A61K 31135

Patent

active

050361066

ABSTRACT:
Methods are described to utilize synergistic interactions by various combinations of (1) bethanidine and various tricyclic compounds, (2) bethanidine and bretylium tosylate, (3) bretylium tosylate and various tricyclic compounds, and (4) debrisoquin sulfate and various tricyclic compounds, preferably in a single injectable or oral dosage form, to prevent, treat, and reduce the vulnerability of the heart to ventricular fibrillation and other ventricular arrhythmias in animals, both human and otherwise. Also, the use of bethanidine and bretylium tosylate in combination, and the use of debrisoquin sulfate for the resuscitation of pulseless beings, the use of debrisoquin sulfate for the suppression of ventricular fibrillation and ventricular tachycardia, and the use of bethanidine as an antidote to tricyclic antidepressant toxicity are disclosed.

REFERENCES:
patent: 4001433 (1977-01-01), Maxwell et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for the treatment of disorders of the cardiac vascular s does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of disorders of the cardiac vascular s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of disorders of the cardiac vascular s will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1542943

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.